Search

Search Constraints

You searched for: Author/Creator Baber, U

Search Results

2. Are the minor high bleeding risk criteria of the academic research consortium truly minor? Insights from a high-volume tertiary care pci centre. (25th November 2020)

3. Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis. (3rd October 2022)

4. Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on‐treatment platelet reactivity. Issue 3 (20th June 2016)

5. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis. (14th October 2021)

6. Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study. (3rd October 2022)

8. Impact of high-density lipoprotein levels in males and females undergoing percutaneous coronary intervention with drug eluting stents. (25th November 2020)

9. Impact of left ventricular ejection fraction on clinical outcomes in females undergoing percutaneous coronary intervention with drug-eluting stents. (14th October 2021)

10. Intersection of the Academic Research Consortium – high bleeding risk criteria in patients undergoing PCI for acute coronary syndromes: insights from a high-volume single centre registry. (25th November 2020)